---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-146289"
form_type: "8-K"
ticker: "ZLAB"
cik: "0001704292"
company_name: "Zai Lab Ltd"
filed_at: "2022-05-10T23:59:59+00:00"
generated_at: "2026-06-25T21:49:00.632158+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Zai Lab Q1 2022 results; excerpts lack financials; auditor, share split, COO announced

## Summary
- Announced Q1 2022 financial results on May 10, 2022; specific revenue and earnings figures not visible in the provided excerpt.
- Engaged KPMG as independent auditor for FY2022, replacing prior auditor, to comply with PCAOB inspection and Nasdaq listing requirements.
- Shareholders approved 1-for-10 ordinary share subdivision effective March 30, 2022, aimed at increasing liquidity and lowering trading price.
- Appointed Josh Smiley as COO effective August 2022; he brings over 26 years of biopharmaceutical industry experience.

## SEC filing metadata
- accession: 0001193125-22-146289
- form_type: 8-K
- ticker: ZLAB
- cik: 0001704292
- company_name: Zai Lab Ltd
- filed_at: 2022-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704292/000119312522146289/0001193125-22-146289-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704292/000119312522146289/d315602d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-146289
- JSON: https://secwatch.observer/filing/0001193125-22-146289.json
- Plain text: https://secwatch.observer/filing/0001193125-22-146289.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.